These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. Ye J; Gradoville L; Daigle D; Miller G J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302 [TBL] [Abstract][Full Text] [Related]
5. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma. Jiang Y; Xu D; Zhao Y; Zhang L PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial protein, TBRG4, modulates KSHV and EBV reactivation from latency. Zhang H; Wong JP; Ni G; Cano P; Dittmer DP; Damania B PLoS Pathog; 2022 Nov; 18(11):e1010990. PubMed ID: 36417478 [TBL] [Abstract][Full Text] [Related]
7. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus. Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739 [TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle. Sadagopan S; Valiya Veettil M; Paudel N; Bottero V; Chandran B J Virol; 2011 Mar; 85(6):2666-85. PubMed ID: 21209106 [TBL] [Abstract][Full Text] [Related]
9. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection. Callahan J; Pai S; Cotter M; Robertson ES Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337 [TBL] [Abstract][Full Text] [Related]
10. Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells. Spadavecchia S; Gonzalez-Lopez O; Carroll KD; Palmeri D; Lukac DM J Virol; 2010 Oct; 84(20):10488-500. PubMed ID: 20686042 [TBL] [Abstract][Full Text] [Related]
11. Pomalidomide increases immune surface marker expression and immune recognition of oncovirus-infected cells. Davis DA; Shrestha P; Aisabor AI; Stream A; Galli V; Pise-Masison CA; Tagawa T; Ziegelbauer JM; Franchini G; Yarchoan R Oncoimmunology; 2019; 8(2):e1546544. PubMed ID: 30713808 [TBL] [Abstract][Full Text] [Related]
12. Multifaceted roles for STAT3 in gammaherpesvirus latency revealed through Hogan CH; Owens SM; Reynoso GV; Liao Y; Meyer TJ; Zelazowska MA; Liu B; Li X; Grosskopf AK; Khairallah C; Kirillov V; Reich NC; Sheridan BS; McBride KM; Gewurz BE; Hickman HD; Forrest JC; Krug LT mBio; 2024 Feb; 15(2):e0299823. PubMed ID: 38170993 [TBL] [Abstract][Full Text] [Related]
13. Circular DNA tumor viruses make circular RNAs. Toptan T; Abere B; Nalesnik MA; Swerdlow SH; Ranganathan S; Lee N; Shair KH; Moore PS; Chang Y Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8737-E8745. PubMed ID: 30150410 [TBL] [Abstract][Full Text] [Related]
14. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. Miller G; Heston L; Grogan E; Gradoville L; Rigsby M; Sun R; Shedd D; Kushnaryov VM; Grossberg S; Chang Y J Virol; 1997 Jan; 71(1):314-24. PubMed ID: 8985352 [TBL] [Abstract][Full Text] [Related]
15. Restoration of immune surface molecules in Kaposi sarcoma-associated herpes virus infected cells by lenalidomide and pomalidomide. Davis DA; Mishra S; Anagho HA; Aisabor AI; Shrestha P; Wang V; Takamatsu Y; Maeda K; Mitsuya H; Zeldis JB; Yarchoan R Oncotarget; 2017 Aug; 8(31):50342-50358. PubMed ID: 28881567 [TBL] [Abstract][Full Text] [Related]
16. Immune checkpoints in T cells during oncogenic γ-herpesvirus infections. Münz C J Med Virol; 2023 Jan; 95(1):e27840. PubMed ID: 35524342 [TBL] [Abstract][Full Text] [Related]
17. Gammaherpesvirus Infection of Human Neuronal Cells. Jha HC; Mehta D; Lu J; El-Naccache D; Shukla SK; Kovacsics C; Kolson D; Robertson ES mBio; 2015 Dec; 6(6):e01844-15. PubMed ID: 26628726 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus. Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324 [TBL] [Abstract][Full Text] [Related]
20. The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II. Quinn LL; Williams LR; White C; Forrest C; Zuo J; Rowe M J Virol; 2016 Jan; 90(1):356-67. PubMed ID: 26468525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]